Cassava Sciences Inc (SAVA)
20.82
+0.33
(+1.61%)
USD |
NASDAQ |
Apr 23, 13:05
Cassava Sciences Total Liabilities (Quarterly): 14.20M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 14.20M |
September 30, 2023 | 17.41M |
June 30, 2023 | 17.90M |
March 31, 2023 | 14.11M |
December 31, 2022 | 7.295M |
September 30, 2022 | 8.567M |
June 30, 2022 | 9.011M |
March 31, 2022 | 7.097M |
December 31, 2021 | 12.87M |
September 30, 2021 | 6.684M |
June 30, 2021 | 4.825M |
March 31, 2021 | 2.863M |
December 31, 2020 | 2.10M |
September 30, 2020 | 1.426M |
June 30, 2020 | 1.314M |
March 31, 2020 | 1.145M |
December 31, 2019 | 1.387M |
September 30, 2019 | 0.93M |
June 30, 2019 | 0.982M |
March 31, 2019 | 0.97M |
December 31, 2018 | 0.511M |
September 30, 2018 | 0.862M |
June 30, 2018 | 1.287M |
March 31, 2018 | 0.758M |
December 31, 2017 | 1.132M |
Date | Value |
---|---|
September 30, 2017 | 1.01M |
June 30, 2017 | 0.999M |
March 31, 2017 | 0.883M |
December 31, 2016 | 0.665M |
September 30, 2016 | 2.167M |
June 30, 2016 | 1.953M |
March 31, 2016 | 3.344M |
December 31, 2015 | 2.551M |
September 30, 2015 | 2.586M |
June 30, 2015 | 1.813M |
March 31, 2015 | 1.20M |
December 31, 2014 | 0.85M |
September 30, 2014 | 2.383M |
June 30, 2014 | 1.739M |
March 31, 2014 | 1.618M |
December 31, 2013 | 1.801M |
September 30, 2013 | 37.50M |
June 30, 2013 | 39.02M |
March 31, 2013 | 41.46M |
December 31, 2012 | 43.72M |
September 30, 2012 | 46.93M |
June 30, 2012 | 48.27M |
March 31, 2012 | 51.51M |
December 31, 2011 | 54.57M |
September 30, 2011 | 57.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.93M
Minimum
Sep 2019
17.90M
Maximum
Jun 2023
6.953M
Average
6.684M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
Amylyx Pharmaceuticals Inc | 84.02M |
MannKind Corp | 721.37M |
Clearside Biomedical Inc | 49.93M |
Lantern Pharma Inc | 2.740M |
NovaBay Pharmaceuticals Inc | 5.72M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 151.66M |
Shareholders Equity (Quarterly) | 137.47M |